Last 36.05 INR
Change Today +2.05 / 6.03%
Volume 93.8K
As of 5:10 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

beryl drugs ltd (BRD) Snapshot

Open
34.00
Previous Close
34.00
Day High
38.75
Day Low
33.10
52 Week High
03/7/14 - 48.00
52 Week Low
05/21/14 - 18.95
Market Cap
182.8M
Average Volume 10 Days
103.8K
EPS TTM
0.17
Shares Outstanding
5.1M
EX-Date
--
P/E TM
212.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for BERYL DRUGS LTD (BRD)

Related News

No related news articles were found.

beryl drugs ltd (BRD) Related Businessweek News

No Related Businessweek News Found

beryl drugs ltd (BRD) Details

Beryl Drugs Ltd. manufactures and markets generic pharmaceutical formulations in India. The company offers small volume injectables in liquid and dry powder form, eye and ear drops, I.V. fluids in polypack and glass bottles, and veterinary medicines. It also provides research and development, and contract manufacturing services. Beryl Drugs Ltd. was founded in 1993 and is based in Indore, India.

Founded in 1993

beryl drugs ltd (BRD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beryl drugs ltd (BRD) Key Developments

Beryl Drugs Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Beryl Drugs Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported income from sales/services of INR 28,560,000 compared to INR 37,387,000 a year ago. Profit from operations before other income, interest and tax was INR 1,360,000 compared to INR 2,152,000 a year ago. Profit before tax was INR 919,000 compared to INR 1,759,000 a year ago. Net profit was INR 619,000 or INR 0.12 per basic and diluted share compared to INR 1,459,000 or INR 0.28 per basic and diluted share a year ago. For the nine months period, the company reported income from sales/services of INR 98,329,000 compared to INR 123,553,000 a year ago. Profit from operations before other income, interest and tax was INR 4,954,000 compared to INR 6,016,000 a year ago. Profit before tax was INR 3,670,000 compared to INR 5,216,000 a year ago. Net profit was INR 2,870,000 or INR 0.57 per basic and diluted share compared to INR 4,516,000 or INR 0.88 per basic and diluted share a year ago.

Beryl Drugs Ltd., Board Meeting, Jan 20, 2015

Beryl Drugs Ltd., Board Meeting, Jan 20, 2015. Agenda: To consider quarterly results; and to consider and approve appointment of Mrs. Neha Sharma as Compliance Officer of the company.

Beryl Drugs Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Beryl Drugs Ltd. reported unaudited earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported income from sales was INR 33,281,000 compared to INR 40,508,000 reported a year ago. Profit from operations before other income, interest and tax of INR 2,228,000 compared to INR 1,766,000 reported a year ago. Profit before tax was INR 2,454,000 against INR 2,072,000 a year ago. Net profit was INR 1,545,000 or INR 0.30 per basic and diluted share compared to net profit of INR 1,290,000 or INR 0.25 per basic and diluted share reported a year ago. For the nine months, the company reported income from sales was INR 69,769,000 compared to INR 86,166,000 reported a year ago. Profit from operations before other income, interest and tax of INR 3,594,000 compared to INR 3,864,000 reported a year ago. Profit before tax was INR 3,953,000 against INR 4,289,000 a year ago. Net profit was INR 2,251,000 or INR 0.44 per basic and diluted share compared to net profit of INR 3,057,000 or INR 0.60 per basic and diluted share reported a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRD:IN 36.05 INR +2.05

BRD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BRD.
View Industry Companies
 

Industry Analysis

BRD

Industry Average

Valuation BRD Industry Range
Price/Earnings 100.0x
Price/Sales 1.5x
Price/Book -- Not Meaningful
Price/Cash Flow 41.2x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BERYL DRUGS LTD, please visit www.beryldrugs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.